A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating
inflammation, or treating cancer may comprise administering a
therapeutically effective amount of an extract of Maytenus abenfolia to a
patient. A medicament as described herein may comprise a pharmaceutically
acceptable vehicle and a therapeutically effective amount of an extract
of Maytenus abenfolia suspended in the vehicle. A method of making an
extract of Maytenus abenfolia may comprise creating a component solution
by treating Maytenus abenfolia material with an extractor and a solvent
and producing an extract by at least partially removing liquid from the
component solution. An extract of Maytenus abenfolia may comprise
components extracted using various solvents.